2012 -- H 7234 | |
======= | |
LC00608 | |
======= | |
STATE OF RHODE ISLAND | |
| |
IN GENERAL ASSEMBLY | |
| |
JANUARY SESSION, A.D. 2012 | |
| |
____________ | |
| |
A N A C T | |
RELATING TO HEALTH AND SAFETY - DIABETES SCREENING AND RISK | |
REDUCTION PILOT PROGRAM | |
|
      |
|
      |
     Introduced By: Representatives Naughton, E Coderre, Diaz, Silva, and Morrison | |
     Date Introduced: January 25, 2012 | |
     Referred To: House Health, Education & Welfare | |
It is enacted by the General Assembly as follows: | |
1-1 |
     WHEREAS, Undiagnosed type 2 diabetes has become a common condition in the United |
1-2 |
States, compromising one-third (1/3) of all cases of the disease. We believe that screening for and |
1-3 |
detection of undiagnosed type 2 diabetes is an important endeavor. Diabetes is a condition that is |
1-4 |
appropriate for population screening and detection; and |
1-5 |
     WHEREAS, Type 2 diabetes is a significant health problem. It affects more than twenty- |
1-6 |
three million adults in the United States and places these individuals at high risk for serious |
1-7 |
complications of the eyes, nerves, kidneys, and cardiovascular system. |
1-8 |
     WHEREAS, There is a latent phase before diagnosis of type 2 diabetes. During this |
1-9 |
period of undiagnosed disease, risk factors for diabetic micro and macro-vascular complications |
1-10 |
are markedly elevated and diabetic complications are developing; and |
1-11 |
     WHEREAS, Diagnostic criteria for diabetes have been established and are based on |
1-12 |
plasma glucose values. These criteria define a group of individuals with significant |
1-13 |
hyperglycemia who also have a high frequency of risk factors for micro and macro-vascular |
1-14 |
disease; and |
1-15 |
     WHEREAS, The natural history of type 2 diabetes is understood. In most patients, |
1-16 |
diabetes proceeds inexorably from genetic predisposition, through the stage of insulin resistance |
1-17 |
and hyperinsulinemia, to beta cell failure and overt clinical disease; and |
1-18 |
     WHEREAS, There are effective and acceptable therapies available for type 2 diabetes |
1-19 |
and its complications. Treating hyperglycemia to prevent complications is more effective than |
2-1 |
treating these complications after they have developed. Furthermore, guidelines for treatment to |
2-2 |
prevent cardiovascular disease in people known to have diabetes are more stringent than in those |
2-3 |
individuals who are not known to have diabetes; and |
2-4 |
     WHEREAS, There is a suitable test for screening for undiagnosed type 2 diabetes that |
2-5 |
has a high sensitivity and specificity-measurement of fasting plasma glucose. Guidelines for |
2-6 |
identifying persons at high risk for diabetes have been established; and |
2-7 |
     WHEREAS, People with undiagnosed diabetes have medical expenditures that are about |
2-8 |
two and three tenths percent (2.3%) times higher than medical expenditures for people without |
2-9 |
diabetes; and |
2-10 |
     WHEREAS, Diabetes is preventable and controllable; and |
2-11 |
     WHEREAS, For people with pre-diabetes, lifestyle changes, including a five through |
2-12 |
seven percent (5-7%) weight loss and at least one hundred and fifty (150) minutes of physical |
2-13 |
activity per week, can reduce the rate of onset of type 2 diabetes by fifty-eight percent (58%); and |
2-14 |
     WHEREAS, Disability and premature death are not inevitable consequences of diabetes. |
2-15 |
By working with their support network and health care providers, people with diabetes can |
2-16 |
prevent premature death and disability by controlling their blood glucose, blood pressure, and |
2-17 |
blood lipids and by receiving other preventative care in a timely manner; and |
2-18 |
     WHEREAS, Twenty-three million, six hundred thousand people in the United States |
2-19 |
(seven and eight tenths percent (7.8%) of the total population) have diabetes. Of these, five |
2-20 |
million, seven hundred thousand (5,700,000) have undiagnosed diabetes; and |
2-21 |
     WHEREAS, From 1999 though 2000, seven percent (7%) of United States adolescents |
2-22 |
aged twelve through nineteen (12-19) years had impaired fasting glucose (pre-diabetes), putting |
2-23 |
them at increased risk of developing type 2 diabetes, heart disease, and stroke; and |
2-24 |
     WHEREAS, In 2007, approximately one million, six hundred thousand (1,600,000) new |
2-25 |
cases of diabetes were diagnosed in people aged twenty (20) years or older; and |
2-26 |
     WHEREAS, Diabetes is the leading cause of new cases of blindness, kidney failure, and |
2-27 |
non-traumatic lower extremity amputations among adults; and |
2-28 |
     WHEREAS, Diabetes was the sixth (6th) leading cause of death on United States death |
2-29 |
certificates in 2006. Overall, the risk of death among people with diabetes is about twice that of |
2-30 |
people without diabetes of similar age; and |
2-31 |
     WHEREAS, There is a need for diabetes screening for low-income, underinsured, or |
2-32 |
uninsured adults and the United States Center for Disease Control and Prevention has guidelines |
2-33 |
for diabetes screening, disease risk factor screening, lifestyle intervention, and referral services in |
2-34 |
an effort to prevent diabetes and its serious complications such as cardiovascular disease and to |
3-1 |
promote healthy lifestyles; and |
3-2 |
     WHEREAS, Standard preventative services, including diabetic screening, blood pressure |
3-3 |
and cholesterol testing and, lifestyle programs targeting poor nutrition, physical inactivity, and |
3-4 |
smoking; and |
3-5 |
     WHEREAS, Rhode Island is currently not participating in diabetic screening programs |
3-6 |
due to lack of federal funding; and |
3-7 |
     WHEREAS, The best chance for this state to reduce mortality rates due to diabetic |
3-8 |
disease is through education and prevention. |
3-9 |
     SECTION 1. Title 23 of the General Laws entitled "HEALTH AND SAFETY" is hereby |
3-10 |
amended by adding thereto the following chapter: |
3-11 |
     CHAPTER 86.1 |
3-12 |
DIABETES SCREENING AND RISK REDUCTION PILOT PROGRAM |
3-13 |
     23-86.1-1. Diabetes screening and risk reduction pilot program. – (a) The department |
3-14 |
of health (hereinafter, "the department") shall develop a diabetes disease screening and lifestyle |
3-15 |
intervention pilot program at one site in one of Rhode Island's six (6) core cities for low-income, |
3-16 |
underinsured and uninsured, namely Pawtucket, Providence, Woonsocket, Newport, West |
3-17 |
Warwick or Central Falls. |
3-18 |
     (b) The department shall develop the program based on the federal Center for Disease |
3-19 |
Control and Prevention's guidelines. The pilot program shall employ specified measures to gauge |
3-20 |
the impact and outcome of the program. These measures may include the number of people |
3-21 |
served, the number who receive lifestyle interventions, the number of follow-up visits, an |
3-22 |
evaluation of the use of progress markers to reduce risk factors, and a research and evaluation |
3-23 |
component. |
3-24 |
     (c) The department shall prepare an annual report and submit it to the legislature by |
3-25 |
January 31st of each year summarizing the scope and reach of the pilot program. The final report |
3-26 |
shall include a fiscal analysis and a recommendation outlining the benefits and costs of expanding |
3-27 |
the pilot program throughout the state after the program has been in existence for three (3) years. |
3-28 |
The pilot program shall expire on July 1, 2015. |
3-29 |
     (d) Implementation of the diabetes screening and risk reduction pilot program shall be |
3-30 |
subject to appropriation. |
3-31 |
     SECTION 2. This act shall take effect upon passage. |
      | |
======= | |
LC00608 | |
======== | |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY - DIABETES SCREENING AND RISK | |
REDUCTION PILOT PROGRAM | |
*** | |
4-1 |
     This act would establish a diabetes screening and risk reduction program. |
4-2 |
     This act would take effect upon passage. |
      | |
======= | |
LC00608 | |
======= |